Map Pharmaceuticals Inc
MAPP · Chemicals & Drugs · NASDAQ · in our data October 5, 2007 to March 1, 2013 (5.4 years)
The first trading day in our data for Map Pharmaceuticals Inc is October 5, 2007 (its first day in our records, which may be later than its listing and is not its founding). At its peak, on February 28, 2013, the market valued it at $882 million. It left the market when it was bought or merged, last trading at $24.98, -0.1% from its split-adjusted high. Holders got whatever the deal paid, which is not in our price data.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 2007.
Play today's Daily DropAlso gone in 2013: Chemicals & Drugs
- Onyx Pharmaceuticals Inc peaked at $9.9 billion
- Maxygen Inc peaked at $5.8 billion
- Verenium Corp peaked at $4.9 billion
- Santarus Inc peaked at $2.2 billion
- Astex Pharmaceuticals Inc peaked at $1.9 billion
- Savient Pharmaceuticals Inc peaked at $1.6 billion
